Emerging immune therapies in type 1 diabetes and pancreatic islet transplantation

In type 1 diabetes (T1D) the immune system attacks insulin‐producing pancreatic β‐cells. Unfortunately, our ability to curb this pathogenic autoimmune response in a disease‐ and organ‐specific manner is still very limited due to the inchoate understanding of the exact nature and the kinetics of the...

Full description

Saved in:

Bibliographic Details
Published in:	Diabetes, obesity & metabolism Vol. 15; no. 7; pp. 581 - 592
Main Authors:	Schneider, D. A., Kretowicz, A. M., von Herrath, M. G.
Format:	Journal Article
Language:	English
Published:	Oxford, UK Blackwell Publishing Ltd 01.07.2013 Wiley Subscription Services, Inc
Subjects:	Animals Autoimmune diseases Autoimmunity beta cell Biomedical Research - trends clinical trial Diabetes diabetes mellitus Diabetes Mellitus, Type 1 - immunology Diabetes Mellitus, Type 1 - prevention & control Diabetes Mellitus, Type 1 - therapy Humans Immunotherapy - trends islets Islets of Langerhans Transplantation - immunology Islets of Langerhans Transplantation - trends Pancreas Pancreas - immunology Pancreas Transplantation - trends transplantation type 1 diabetes
ISSN:	1462-8902, 1463-1326, 1463-1326
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Be the first to leave a comment!